Clinical Trials Browser

Phase 1 × Terminated × Clofarabine × Clear all

Neoplasms, Leukemia, Myeloid, Acute

NCT00882076 2019-07-24

Clofarabine, Etoposide, and Mitoxantrone for Relapsed and Refractory Acute Leukemias

Phase 1 Terminated

22 enrolled

LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00852709 2018-02-15

POE07-01

Phase 1 Terminated

35 enrolled

LymphoidMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Myeloproliferative Disorders, Recurrence, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Leukemia, Promyelocytic, Acute, Leukemia, Myelomonocytic, Chronic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile, Primary Myelofibrosis

NCT00577694 2015-10-12

Clofarabine and Gemtuzumab in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Phase 1 Terminated

21 enrolled

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute

NCT00081887 2012-08-01

Study of Weekly Clofarabine for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia

Phase 1 Terminated

8 enrolled

LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell

Clinical Trials

Uproleselan With Pre-Transplant Conditioning in Hematopoietic Stem Cell Transplantation for AML

Clofarabine, Etoposide, and Mitoxantrone for Relapsed and Refractory Acute Leukemias

POE07-01

Clofarabine and Gemtuzumab in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Study of Weekly Clofarabine for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia